The Uses and Adverse Effects of Beryllium on Health

Overview

Journal Indian J Occup Environ Med

Date 2010 Apr 14

PMID 20386622

Citations 6

Authors

Ross G Cooper

Adrian P Harrison

Affiliations

Soon will be listed here.

Abstract

Context: This review describes the health effects of beryllium exposure in the workplace and the environment.

Aim: To collate information on the consequences of occupational and environmental exposure to beryllium on physiological function and well being.

Materials And Methods: The criteria used in the current review for selecting articles were adopted from proposed criteria in The International Classification of Functioning, Disability, and Health. Articles were classified based on acute and chronic exposure and toxicity of beryllium.

Results: The proportions of utilized and nonutilized articles were tabulated. Years 2001-10 gave the greatest match (45.9%) for methodological parameters, followed by 27.71% for 1991-2000. Years 1971-80 and 1981-90 were not significantly different in the information published and available whereas years 1951-1960 showed a lack of suitable articles. Some articles were published in sources unobtainable through requests at the British Library, and some had no impact factor and were excluded.

Conclusion: Beryllium has some useful but undoubtedly harmful effects on health and well-being. Measures need to be taken to prevent hazardous exposure to this element, making its biological monitoring in the workplace essential.

Citing Articles

Public health and economic burden of heavy metals in Ethiopia: Review.

Gelaye Y Heliyon. 2024; 10(19):e39022.

PMID: 39430468 PMC: 11490788. DOI: 10.1016/j.heliyon.2024.e39022.

Investigation of the effect of bonding factors on strength of porcelain bond to soft metal alloys after application of thermal cycle.

Ebadian B, Fathi A, Beiranvand N Dent Res J (Isfahan). 2022; 19:91.

PMID: 36426276 PMC: 9680693.

Dynamic wavefront distortion in resonant scanners.

Akondi V, Kowalski B, Dubra A Appl Opt. 2022; 60(36):11189-11195.

PMID: 35201107 PMC: 8887785. DOI: 10.1364/AO.443972.

Trace elements and carcinogenicity: a subject in review.

Mulware S 3 Biotech. 2017; 3(2):85-96.

PMID: 28324563 PMC: 3597132. DOI: 10.1007/s13205-012-0072-6.

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.

Jud A, Kotur M, Berger C, Gysin C, Nadal D, Lunemann A Oncotarget. 2016; 8(4):6130-6141.

PMID: 28008151 PMC: 5351618. DOI: 10.18632/oncotarget.14045.

References

Harper M . A review of workplace aerosol sampling procedures and their relevance to the assessment of beryllium exposures. J Environ Monit. 2006; 8(6):598-604. DOI: 10.1039/b600924g. View

Madl A, Unice K, Brown J, Kolanz M, Kent M . Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant. J Occup Environ Hyg. 2007; 4(6):448-66. DOI: 10.1080/15459620701354747. View

Stange A, Furman F, Hilmas D . The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance. Am J Ind Med. 2004; 46(5):453-62. DOI: 10.1002/ajim.20082. View

Grunewald J, Eklund A . [It's difficult to differentiate between sarcoidosis and berylliosis!]. Lakartidningen. 2001; 97(50):5915-8. View

Sanderson W, Ward E, Steenland K, Petersen M . Lung cancer case-control study of beryllium workers. Am J Ind Med. 2001; 39(2):133-44. DOI: 10.1002/1097-0274(200102)39:2<133::aid-ajim1001>3.0.co;2-7. View

Kolanz M, Madl A, Kelsh M, Kent M, Kalmes R, Paustenbach D . A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease. Appl Occup Environ Hyg. 2001; 16(5):593-614. DOI: 10.1080/10473220119613. View

Steenland K, Ward E . Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst. 1991; 83(19):1380-5. DOI: 10.1093/jnci/83.19.1380. View

Christiani D, Mehta A, Yu C . Genetic susceptibility to occupational exposures. Occup Environ Med. 2008; 65(6):430-6. PMC: 3815576. DOI: 10.1136/oem.2007.033977. View

Fontenot A, Canavera S, Gharavi L, Newman L, Kotzin B . Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest. 2002; 110(10):1473-82. PMC: 151812. DOI: 10.1172/JCI15846. View

10.

Brancaleone P, Weynand B, De Vuyst P, Stanescu D, Pieters T . Lung granulomatosis in a dental technician. Am J Ind Med. 1998; 34(6):628-31. DOI: 10.1002/(sici)1097-0274(199812)34:6<628::aid-ajim12>3.0.co;2-9. View

11.

Muller-Quernheim J, Gaede K, Fireman E, Zissel G . Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J. 2006; 27(6):1190-5. DOI: 10.1183/09031936.06.00112205. View

12.

Ishikawa Y, Kagaya H, Saga K . Biomagnification of 7Be, 234Th, and 228Ra in marine organisms near the northern Pacific coast of Japan. J Environ Radioact. 2004; 76(1-2):103-12. DOI: 10.1016/j.jenvrad.2004.03.021. View

13.

Amicosante M, Deubner D, Saltini C . Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test. Sarcoidosis Vasc Diffuse Lung Dis. 2005; 22(3):175-9. View

14.

Sawyer R, Fadok V, Kittle L, Maier L, Newman L . Beryllium-stimulated apoptosis in macrophage cell lines. Toxicology. 2000; 149(2-3):129-42. DOI: 10.1016/s0300-483x(00)00237-7. View

15.

Dotti C, DApice M, Rogliani P, Novelli G, Saltini C, Amicosante M . Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity. Sarcoidosis Vasc Diffuse Lung Dis. 2004; 21(1):29-34. DOI: 10.1007/s11083-004-9308-3. View

16.

Coates S, Lehnert B, Sharma S, Kindell S, Gary R . Beryllium induces premature senescence in human fibroblasts. J Pharmacol Exp Ther. 2007; 322(1):70-9. DOI: 10.1124/jpet.106.118018. View

17.

Lombardi G, Germain C, Uren J, Fiorillo M, du Bois R, Jones-Williams W . HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol. 2001; 166(5):3549-55. DOI: 10.4049/jimmunol.166.5.3549. View

18.

Tinkle S, Antonini J, Rich B, Roberts J, Salmen R, DePree K . Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003; 111(9):1202-8. PMC: 1241575. DOI: 10.1289/ehp.5999. View

19.

Schuler C, Kent M, Deubner D, Berakis M, McCawley M, Henneberger P . Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005; 47(3):195-205. DOI: 10.1002/ajim.20140. View

20.

Maier L . Genetic and exposure risks for chronic beryllium disease. Clin Chest Med. 2003; 23(4):827-39. DOI: 10.1016/s0272-5231(02)00029-1. View